Skip to content

Follow-up of patients with primary aldosteronism (PA): comparison of surgical and medical treatment

Follow-up of patients with primary aldosteronism (PA): comparison of surgical and medical treatment - Follow-up of patients with primary aldosteronism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32145
Enrollment
80
Registered
2008-05-20
Start date
2008-01-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conn syndrome Primary Aldosteronism

Interventions

None listed

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with primary aldosteronism known in the UMCN St. Radboud in whom CT and/or MRI and/or AVS have been performed

Exclusion criteria

Exclusion criteria: geen

Design outcomes

Primary

MeasureTime frame
Course of blood pressure, medication and laboratory results after operation or after start of PA specific medication (in the non-operated patients)

Secondary

MeasureTime frame
Differences in outcome based on whether a decision to treat was guided by CT/MRI or AVS or both. Differences in outcome between operated and non-operated patients.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)